- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.69%
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
- 100 SMA
- 200 SMA
- 300 SMA
- 400 SMA
- 500 SMA
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|---|---|---|---|---|---|---|---|---|---|
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth | 4.58% | 0.69% | 1.28% | 0.67% | 3.07% | 10.42% | - | - | - | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|---|---|---|---|
89.10% | 4.78% (Arbitrage: 0.00%) | 0.00% | 0.00% | 6.12% |
Equity
Name | Sector | Weight % |
---|---|---|
JB Chemicals & Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 6.94% |
Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 6.81% |
Fortis Healthcare Limited | Healthcare Services | 6.69% |
Cipla Limited | Pharmaceuticals & Biotechnology | 4.56% |
Laurus Labs Limited | Pharmaceuticals & Biotechnology | 4.28% |
Krishna Institute Of Medical Sciences Limited | Healthcare Services | 4.09% |
Neuland Laboratories Limited | Pharmaceuticals & Biotechnology | 3.20% |
Max Healthcare Institute Limited | Healthcare Services | 3.19% |
Lupin Limited | Pharmaceuticals & Biotechnology | 3.14% |
Apollo Hospitals Enterprise Limited | Healthcare Services | 3.05% |
Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 2.89% |
Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 2.77% |
Vijaya Diagnostic Centre Limited | Healthcare Services | 2.48% |
Abbott India Limited | Pharmaceuticals & Biotechnology | 2.14% |
Gland Pharma Limited | Pharmaceuticals & Biotechnology | 1.94% |
Shaily Engineering Plastics Limited | Industrial Products | 1.91% |
Ajanta Pharma Limited | Pharmaceuticals & Biotechnology | 1.75% |
Jupiter Life Line Hospitals Limited | Healthcare Services | 1.66% |
Kovai Medical Center and Hospital Limited | Healthcare Services | 1.65% |
Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 1.64% |
Glenmark Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 1.61% |
GlaxoSmithKline Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 1.58% |
Anthem Biosciences Limited | Pharmaceuticals & Biotechnology | 1.51% |
Pfizer Limited | Pharmaceuticals & Biotechnology | 1.50% |
AstraZeneca Pharma India Limited | Pharmaceuticals & Biotechnology | 1.48% |
Alembic Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 1.40% |
Emcure Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 1.36% |
Eris Lifesciences Limited | Pharmaceuticals & Biotechnology | 1.19% |
Thyrocare Technologies Limited | Healthcare Services | 1.19% |
Poly Medicure Limited | Healthcare Equipment & Supplies | 1.03% |
Acutaas Chemicals Limited | Pharmaceuticals & Biotechnology | 0.94% |
Healthcare Global Enterprises Limited | Healthcare Services | 0.80% |
Dr.Agarwals Eye Hospital Limited | Healthcare Services | 0.79% |
Supriya Lifescience Limited | Pharmaceuticals & Biotechnology | 0.79% |
Navin Fluorine International Limited | Chemicals & Petrochemicals | 0.75% |
Shilpa Medicare Limited | Pharmaceuticals & Biotechnology | 0.70% |
Aster DM Healthcare Limited | Healthcare Services | 0.58% |
Zota Health Care Limited | Pharmaceuticals & Biotechnology | 0.56% |
Piramal Pharma Limited | Pharmaceuticals & Biotechnology | 0.51% |
PB Fintech Limited | Financial Technology (Fintech) | 0.50% |
Jubilant Ingrevia Limited | Chemicals & Petrochemicals | 0.46% |
Orchid Pharma Limited | Pharmaceuticals & Biotechnology | 0.45% |
Onesource Specialty Pharma Limited | Pharmaceuticals & Biotechnology | 0.42% |
Laxmi Dental Limited | Healthcare Equipment & Supplies | 0.22% |
Debt
Name | Rating | Weight % |
---|---|---|
91 Days Tbill (MD 02/10/2025) | Sovereign | 1.13% |
364 Days Tbill (MD 18/12/2025) | Sovereign | 1.12% |
182 Days Tbill (MD 25/12/2025) | Sovereign | 0.67% |
364 Days Tbill (MD 03/10/2025) | Sovereign | 0.45% |
91 Days Tbill (MD 04/12/2025) | Sovereign | 0.45% |
91 Days Tbill (MD 30/10/2025) | Sovereign | 0.27% |
91 Days Tbill (MD 20/11/2025) | Sovereign | 0.22% |
91 Days Tbill (MD 28/11/2025) | Sovereign | 0.22% |
91 Days Tbill (MD 16/10/2025) | Sovereign | 0.11% |
182 Days Tbill (MD 23/10/2025) | Sovereign | 0.09% |
91 Days Tbill (MD 23/10/2025) | Sovereign | 0.05% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth - 30 days NAV history
Date | NAV |
---|---|
20 October, 2025 | 14.648 |
17 October, 2025 | 14.547 |
16 October, 2025 | 14.477 |
15 October, 2025 | 14.396 |
14 October, 2025 | 14.369 |
13 October, 2025 | 14.463 |
10 October, 2025 | 14.450 |
9 October, 2025 | 14.315 |
8 October, 2025 | 14.218 |
7 October, 2025 | 14.262 |
6 October, 2025 | 14.217 |
3 October, 2025 | 14.079 |
1 October, 2025 | 14.100 |
30 September, 2025 | 13.919 |
29 September, 2025 | 13.935 |
26 September, 2025 | 13.888 |
25 September, 2025 | 14.203 |
24 September, 2025 | 14.290 |
23 September, 2025 | 14.359 |
22 September, 2025 | 14.412 |
19 September, 2025 | 14.550 |
18 September, 2025 | 14.547 |
17 September, 2025 | 14.484 |
16 September, 2025 | 14.469 |
15 September, 2025 | 14.432 |
12 September, 2025 | 14.489 |
11 September, 2025 | 14.474 |
10 September, 2025 | 14.437 |
9 September, 2025 | 14.381 |
8 September, 2025 | 14.318 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 14.648 as on 20 October, 2025.What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 4.58% as on 20 October, 2025.What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 10.42% as on 20 October, 2025.